FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

386811000001108: Augmentin 375mg dispersible tablets (GlaxoSmithKline) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16260901000001111 Augmentin 375mg dispersible tablets (GlaxoSmithKline) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
58163501000001112 Augmentin 375mg dispersible tablets (GlaxoSmithKline UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Augmentin 375mg dispersible tablets (GlaxoSmithKline) Is a Amoxicillin + clavulanate potassium 250mg/125mg s/f dispersible tablet false Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) Has dispensed dose form Dispersible tablet true Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) Has active ingredient Bactericide false Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) Has active ingredient Amoxicillin trihydrate false Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) Has active ingredient Amoxicillin true Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) Has active ingredient Clavulanate potassium true Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) Is a Co-amoxiclav 250mg/125mg dispersible tablets sugar free true Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) Is a Product containing only amoxicillin and clavulanic acid in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) Has active ingredient Substance with antibacterial mechanism of action false Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) Is a Augmentin true Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Amoxicillin true Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Clavulanic acid true Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) Has specific active ingredient Amoxicillin trihydrate true Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) Has specific active ingredient Clavulanate potassium true Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) Has dispensed dose form Dispersible tablet false Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) Has basis of strength substance Amoxicillin true Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) Has basis of strength substance Clavulanic acid true Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) Has dispensed dose form Dispersible tablet false Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) Has dispensed dose form Dispersible tablet false Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) Is a Co-amoxiclav 250mg/125mg dispersible tablets sugar free false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Augmentin 375mg dispersible tablets (GlaxoSmithKline) 21 tablet Is pack of False Augmentin 375mg dispersible tablets (GlaxoSmithKline) Inferred relationship Existential restriction modifier
Augmentin 375mg dispersible tablets (GlaxoSmithKline) 21 tablet Has AMP True Augmentin 375mg dispersible tablets (GlaxoSmithKline) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start